APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Esomeprazole

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Esomeprazole Industry Growth and Trends Forecast to 2032

Report ID 173989560120 December 2025108 pages

Choose your research edition.

Industry ResearchEsomeprazole Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Esomeprazole Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Esomeprazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Esomeprazole Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Esomeprazole Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Esomeprazole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Esomeprazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Esomeprazole is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Esomeprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Esomeprazole include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, Garmish Pharmaceuticals, KernPharm, Mepha, Saval Pharmaceutical and Stada, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Esomeprazole market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Esomeprazole market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Esomeprazole market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Esomeprazole.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Esomeprazole market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Esomeprazole Market by Company

Actavis

AstraZeneca AB

Blaskov

CQ Lummy

Garmish Pharmaceuticals

KernPharm

Mepha

Saval Pharmaceutical

Stada

Mylan

Sanofi

Sandoz

Teva.

Esomeprazole Segment by Type

Capsule

Tablet

Others

Esomeprazole Segment by Application

Gastroesophageal Reflux Disease

Duodenal Ulcers

Others

Esomeprazole Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esomeprazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esomeprazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esomeprazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Esomeprazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Esomeprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Tablet Table 3. Major Company of Others Table 4. Global Esomeprazole Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Esomeprazole Sales by Type (2021-2026) & (W Units) Table 6. Global Esomeprazole Sales Market Share in Volume by Type (2021-2026) Table 7. Global Esomeprazole Sales by Type (2021-2026) & (US$ Million) Table 8. Global Esomeprazole Sales Market Share in Value by Type (2021-2026) Table 9. Global Esomeprazole Price by Type (2021-2026) & (US$/Unit) Table 10. Global Esomeprazole Sales by Type (2027-2032) & (W Units) Table 11. Global Esomeprazole Sales Market Share in Volume by Type (2027-2032) Table 12. Global Esomeprazole Sales by Type (2027-2032) & (US$ Million) Table 13. Global Esomeprazole Sales Market Share in Value by Type (2027-2032) Table 14. Global Esomeprazole Price by Type (2027-2032) & (US$/Unit) Table 15. North America Esomeprazole Sales by Type (2021-2026) & (W Units) Table 16. North America Esomeprazole Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Esomeprazole Sales by Type (2021-2026) & (W Units) Table 18. Europe Esomeprazole Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Esomeprazole Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Esomeprazole Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Esomeprazole Sales by Type (2021-2026) & (W Units) Table 22. Latin America Esomeprazole Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Esomeprazole Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Esomeprazole Sales by Type (2021-2026) & (US$ Million) Table 25. Esomeprazole Industry Trends Table 26. Esomeprazole Industry Drivers Table 27. Esomeprazole Industry Opportunities and Challenges Table 28. Esomeprazole Industry Restraints Table 29. Global Esomeprazole Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Esomeprazole Revenue Market Share by Company (2021-2026) Table 31. Global Esomeprazole Sales by Company (2021-2026) & (W Units) Table 32. Global Esomeprazole Sales Share by Company (2021-2026) Table 33. Global Esomeprazole Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Esomeprazole Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Esomeprazole Major Company Production Sites and Headquarters Table 36. Global Esomeprazole Company, Product Type & Application Table 37. Global Esomeprazole Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Esomeprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Esomeprazole Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Esomeprazole Sales by Region (2021-2026) & (W Units) Table 42. Global Esomeprazole Sales Market Share in Volume by Region (2021-2026) Table 43. Global Esomeprazole Sales by Region (2021-2026) & (US$ Million) Table 44. Global Esomeprazole Sales Market Share in Value by Region (2021-2026) Table 45. Global Esomeprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Esomeprazole Sales by Region (2027-2032) & (W Units) Table 47. Global Esomeprazole Sales Market Share in Volume by Region (2027-2032) Table 48. Global Esomeprazole Sales by Region (2027-2032) & (US$ Million) Table 49. Global Esomeprazole Sales Market Share in Value by Region (2027-2032) Table 50. Global Esomeprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Esomeprazole Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Esomeprazole Sales by Application (2021-2026) & (W Units) Table 53. Global Esomeprazole Sales Market Share in Volume by Application (2021-2026) Table 54. Global Esomeprazole Sales by Application (2021-2026) & (US$ Million) Table 55. Global Esomeprazole Sales Market Share in Value by Application (2021-2026) Table 56. Global Esomeprazole Price by Application (2021-2026) & (US$/Unit) Table 57. Global Esomeprazole Sales by Application (2027-2032) & (W Units) Table 58. Global Esomeprazole Sales Market Share in Volume by Application (2027-2032) Table 59. Global Esomeprazole Sales by Application (2027-2032) & (US$ Million) Table 60. Global Esomeprazole Sales Market Share in Value by Application (2027-2032) Table 61. Global Esomeprazole Price by Application (2027-2032) & (US$/Unit) Table 62. North America Esomeprazole Sales by Application (2021-2026) & (W Units) Table 63. North America Esomeprazole Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Esomeprazole Sales by Application (2021-2026) & (W Units) Table 65. Europe Esomeprazole Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Esomeprazole Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Esomeprazole Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Esomeprazole Sales by Application (2021-2026) & (W Units) Table 69. Latin America Esomeprazole Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Esomeprazole Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Esomeprazole Sales by Application (2021-2026) & (US$ Million) Table 72. Actavis Company Information Table 73. Actavis Business Overview Table 74. Actavis Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Actavis Esomeprazole Product Portfolio Table 76. Actavis Recent Development Table 77. AstraZeneca AB Company Information Table 78. AstraZeneca AB Business Overview Table 79. AstraZeneca AB Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. AstraZeneca AB Esomeprazole Product Portfolio Table 81. AstraZeneca AB Recent Development Table 82. Blaskov Company Information Table 83. Blaskov Business Overview Table 84. Blaskov Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Blaskov Esomeprazole Product Portfolio Table 86. Blaskov Recent Development Table 87. CQ Lummy Company Information Table 88. CQ Lummy Business Overview Table 89. CQ Lummy Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. CQ Lummy Esomeprazole Product Portfolio Table 91. CQ Lummy Recent Development Table 92. Garmish Pharmaceuticals Company Information Table 93. Garmish Pharmaceuticals Business Overview Table 94. Garmish Pharmaceuticals Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Garmish Pharmaceuticals Esomeprazole Product Portfolio Table 96. Garmish Pharmaceuticals Recent Development Table 97. KernPharm Company Information Table 98. KernPharm Business Overview Table 99. KernPharm Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. KernPharm Esomeprazole Product Portfolio Table 101. KernPharm Recent Development Table 102. Mepha Company Information Table 103. Mepha Business Overview Table 104. Mepha Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mepha Esomeprazole Product Portfolio Table 106. Mepha Recent Development Table 107. Saval Pharmaceutical Company Information Table 108. Saval Pharmaceutical Business Overview Table 109. Saval Pharmaceutical Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Saval Pharmaceutical Esomeprazole Product Portfolio Table 111. Saval Pharmaceutical Recent Development Table 112. Stada Company Information Table 113. Stada Business Overview Table 114. Stada Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Stada Esomeprazole Product Portfolio Table 116. Stada Recent Development Table 117. Mylan Company Information Table 118. Mylan Business Overview Table 119. Mylan Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Mylan Esomeprazole Product Portfolio Table 121. Mylan Recent Development Table 122. Sanofi Company Information Table 123. Sanofi Business Overview Table 124. Sanofi Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sanofi Esomeprazole Product Portfolio Table 126. Sanofi Recent Development Table 127. Sandoz Company Information Table 128. Sandoz Business Overview Table 129. Sandoz Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Sandoz Esomeprazole Product Portfolio Table 131. Sandoz Recent Development Table 132. Teva. Company Information Table 133. Teva. Business Overview Table 134. Teva. Esomeprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Teva. Esomeprazole Product Portfolio Table 136. Teva. Recent Development Table 137. North America Esomeprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 138. North America Esomeprazole Sales by Country (2021-2026) & (W Units) Table 139. North America Esomeprazole Sales Market Share by Country (2021-2026) Table 140. North America Esomeprazole Sales Forecast by Country (2027-2032) & (W Units) Table 141. North America Esomeprazole Sales Market Share Forecast by Country (2027-2032) Table 142. North America Esomeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Esomeprazole Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Esomeprazole Market Share by Country (2021-2026) Table 145. North America Esomeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Esomeprazole Market Share Forecast by Country (2027-2032) Table 147. Europe Esomeprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 148. Europe Esomeprazole Sales by Country (2021-2026) & (W Units) Table 149. Europe Esomeprazole Sales Market Share by Country (2021-2026) Table 150. Europe Esomeprazole Sales Forecast by Country (2027-2032) & (W Units) Table 151. Europe Esomeprazole Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Esomeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Esomeprazole Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Esomeprazole Market Share by Country (2021-2026) Table 155. Europe Esomeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Esomeprazole Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Esomeprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Esomeprazole Sales by Country (2021-2026) & (W Units) Table 159. Asia-Pacific Esomeprazole Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Esomeprazole Sales Forecast by Country (2027-2032) & (W Units) Table 161. Asia-Pacific Esomeprazole Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Esomeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Esomeprazole Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Esomeprazole Market Share by Country (2021-2026) Table 165. Asia-Pacific Esomeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Esomeprazole Market Share Forecast by Country (2027-2032) Table 167. Latin America Esomeprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 168. Latin America Esomeprazole Sales by Country (2021-2026) & (W Units) Table 169. Latin America Esomeprazole Sales Market Share by Country (2021-2026) Table 170. Latin America Esomeprazole Sales Forecast by Country (2027-2032) & (W Units) Table 171. Latin America Esomeprazole Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Esomeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Esomeprazole Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Esomeprazole Market Share by Country (2021-2026) Table 175. Latin America Esomeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Esomeprazole Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Esomeprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Esomeprazole Sales by Country (2021-2026) & (W Units) Table 179. Middle East and Africa Esomeprazole Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Esomeprazole Sales Forecast by Country (2027-2032) & (W Units) Table 181. Middle East and Africa Esomeprazole Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Esomeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Esomeprazole Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Esomeprazole Market Share by Country (2021-2026) Table 185. Middle East and Africa Esomeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Esomeprazole Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Esomeprazole Distributors List Table 190. Esomeprazole Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Esomeprazole Image Figure 2. Global Esomeprazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esomeprazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Esomeprazole Sales (2021-2032) & (W Units) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (W Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Esomeprazole Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Esomeprazole Market Share by Type 2025 VS 2032 Figure 13. North America Esomeprazole Sales Market Share in Volume by Type in 2025 Figure 14. North America Esomeprazole Sales Market Share in Value by Type in 2025 Figure 15. Europe Esomeprazole Sales Market Share in Volume by Type in 2025 Figure 16. Europe Esomeprazole Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Esomeprazole Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Esomeprazole Sales Market Share in Value by Type in 2025 Figure 19. Latin America Esomeprazole Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Esomeprazole Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Esomeprazole Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Esomeprazole Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Esomeprazole Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Gastroesophageal Reflux Disease Image Figure 26. Global Gastroesophageal Reflux Disease Sales YoY Growth (2021-2032) & (W Units) Figure 27. Duodenal Ulcers Image Figure 28. Global Duodenal Ulcers Sales YoY Growth (2021-2032) & (W Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Esomeprazole Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Esomeprazole Market Share by Application 2025 VS 2032 Figure 33. North America Esomeprazole Sales Market Share in Volume by Application in 2025 Figure 34. North America Esomeprazole Sales Market Share in Value by Application in 2025 Figure 35. Europe Esomeprazole Sales Market Share in Volume by Application in 2025 Figure 36. Europe Esomeprazole Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Esomeprazole Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Esomeprazole Sales Market Share in Value by Application in 2025 Figure 39. Latin America Esomeprazole Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Esomeprazole Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Esomeprazole Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Esomeprazole Sales Market Share in Value by Application in 2025 Figure 43. North America Esomeprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Esomeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Esomeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Esomeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Esomeprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Esomeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Esomeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Esomeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Esomeprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Esomeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Esomeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Esomeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Esomeprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Esomeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Esomeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Esomeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Esomeprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Esomeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Esomeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Esomeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Esomeprazole Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Esomeprazole Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
  • Others
Applications
  • Gastroesophageal Reflux Disease
  • Duodenal Ulcers
  • Others
Companies covered
  • Actavis
  • AstraZeneca AB
  • Blaskov
  • CQ Lummy
  • Garmish Pharmaceuticals
  • KernPharm
  • Mepha
  • Saval Pharmaceutical
  • Stada
  • Mylan
  • Sanofi
  • Sandoz
  • Teva.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Esomeprazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Esomeprazole Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Esomeprazole Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Tablet
  8. 1.3.3 Others
  9. 1.4 Global Esomeprazole Market Size by Type
  10. 1.4.1 Global Esomeprazole Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Esomeprazole Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Esomeprazole Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Esomeprazole Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Esomeprazole Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Esomeprazole Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Esomeprazole Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Esomeprazole Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Esomeprazole Industry Trends
  2. 2.2 Esomeprazole Industry Drivers
  3. 2.3 Esomeprazole Industry Opportunities and Challenges
  4. 2.4 Esomeprazole Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Esomeprazole Revenue (2021-2026)
  2. 3.2 Global Top Players by Esomeprazole Sales (2021-2026)
  3. 3.3 Global Top Players by Esomeprazole Price (2021-2026)
  4. 3.4 Global Esomeprazole Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Esomeprazole Major Company Production Sites & Headquarters
  6. 3.6 Global Esomeprazole Company, Product Type & Application
  7. 3.7 Global Esomeprazole Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Esomeprazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Esomeprazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Esomeprazole Tier 1, Tier 2, and Tier 3
4 Esomeprazole Regional Status and Outlook
  1. 4.1 Global Esomeprazole Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Esomeprazole Historic Market Size by Region
  3. 4.2.1 Global Esomeprazole Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Esomeprazole Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Esomeprazole Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Esomeprazole Forecasted Market Size by Region
  7. 4.3.1 Global Esomeprazole Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Esomeprazole Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Esomeprazole Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Esomeprazole by Application
  1. 5.1 Esomeprazole Market by Application
  2. 5.1.1 Gastroesophageal Reflux Disease
  3. 5.1.2 Duodenal Ulcers
  4. 5.1.3 Others
  5. 5.2 Global Esomeprazole Market Size by Application
  6. 5.2.1 Global Esomeprazole Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Esomeprazole Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Esomeprazole Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Esomeprazole Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Esomeprazole Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Esomeprazole Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Esomeprazole Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Esomeprazole Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actavis
  2. 6.1.1 Actavis Company Information
  3. 6.1.2 Actavis Business Overview
  4. 6.1.3 Actavis Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actavis Esomeprazole Product Portfolio
  6. 6.1.5 Actavis Recent Developments
  7. 6.2 AstraZeneca AB
  8. 6.2.1 AstraZeneca AB Company Information
  9. 6.2.2 AstraZeneca AB Business Overview
  10. 6.2.3 AstraZeneca AB Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca AB Esomeprazole Product Portfolio
  12. 6.2.5 AstraZeneca AB Recent Developments
  13. 6.3 Blaskov
  14. 6.3.1 Blaskov Company Information
  15. 6.3.2 Blaskov Business Overview
  16. 6.3.3 Blaskov Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Blaskov Esomeprazole Product Portfolio
  18. 6.3.5 Blaskov Recent Developments
  19. 6.4 CQ Lummy
  20. 6.4.1 CQ Lummy Company Information
  21. 6.4.2 CQ Lummy Business Overview
  22. 6.4.3 CQ Lummy Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CQ Lummy Esomeprazole Product Portfolio
  24. 6.4.5 CQ Lummy Recent Developments
  25. 6.5 Garmish Pharmaceuticals
  26. 6.5.1 Garmish Pharmaceuticals Company Information
  27. 6.5.2 Garmish Pharmaceuticals Business Overview
  28. 6.5.3 Garmish Pharmaceuticals Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Garmish Pharmaceuticals Esomeprazole Product Portfolio
  30. 6.5.5 Garmish Pharmaceuticals Recent Developments
  31. 6.6 KernPharm
  32. 6.6.1 KernPharm Company Information
  33. 6.6.2 KernPharm Business Overview
  34. 6.6.3 KernPharm Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 KernPharm Esomeprazole Product Portfolio
  36. 6.6.5 KernPharm Recent Developments
  37. 6.7 Mepha
  38. 6.7.1 Mepha Company Information
  39. 6.7.2 Mepha Business Overview
  40. 6.7.3 Mepha Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mepha Esomeprazole Product Portfolio
  42. 6.7.5 Mepha Recent Developments
  43. 6.8 Saval Pharmaceutical
  44. 6.8.1 Saval Pharmaceutical Company Information
  45. 6.8.2 Saval Pharmaceutical Business Overview
  46. 6.8.3 Saval Pharmaceutical Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Saval Pharmaceutical Esomeprazole Product Portfolio
  48. 6.8.5 Saval Pharmaceutical Recent Developments
  49. 6.9 Stada
  50. 6.9.1 Stada Company Information
  51. 6.9.2 Stada Business Overview
  52. 6.9.3 Stada Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Stada Esomeprazole Product Portfolio
  54. 6.9.5 Stada Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Esomeprazole Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Esomeprazole Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
  67. 6.12 Sandoz
  68. 6.12.1 Sandoz Company Information
  69. 6.12.2 Sandoz Business Overview
  70. 6.12.3 Sandoz Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sandoz Esomeprazole Product Portfolio
  72. 6.12.5 Sandoz Recent Developments
  73. 6.13 Teva.
  74. 6.13.1 Teva. Company Information
  75. 6.13.2 Teva. Business Overview
  76. 6.13.3 Teva. Esomeprazole Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Teva. Esomeprazole Product Portfolio
  78. 6.13.5 Teva. Recent Developments
7 North America by Country
  1. 7.1 North America Esomeprazole Sales by Country
  2. 7.1.1 North America Esomeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Esomeprazole Sales by Country (2021-2026)
  4. 7.1.3 North America Esomeprazole Sales Forecast by Country (2027-2032)
  5. 7.2 North America Esomeprazole Market Size by Country
  6. 7.2.1 North America Esomeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Esomeprazole Market Size by Country (2021-2026)
  8. 7.2.3 North America Esomeprazole Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Esomeprazole Sales by Country
  2. 8.1.1 Europe Esomeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Esomeprazole Sales by Country (2021-2026)
  4. 8.1.3 Europe Esomeprazole Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Esomeprazole Market Size by Country
  6. 8.2.1 Europe Esomeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Esomeprazole Market Size by Country (2021-2026)
  8. 8.2.3 Europe Esomeprazole Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Esomeprazole Sales by Country
  2. 9.1.1 Asia-Pacific Esomeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Esomeprazole Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Esomeprazole Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Esomeprazole Market Size by Country
  6. 9.2.1 Asia-Pacific Esomeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Esomeprazole Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Esomeprazole Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Esomeprazole Sales by Country
  2. 10.1.1 South America Esomeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Esomeprazole Sales by Country (2021-2026)
  4. 10.1.3 South America Esomeprazole Sales Forecast by Country (2027-2032)
  5. 10.2 South America Esomeprazole Market Size by Country
  6. 10.2.1 South America Esomeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Esomeprazole Market Size by Country (2021-2026)
  8. 10.2.3 South America Esomeprazole Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Esomeprazole Sales by Country
  2. 11.1.1 Middle East and Africa Esomeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Esomeprazole Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Esomeprazole Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Esomeprazole Market Size by Country
  6. 11.2.1 Middle East and Africa Esomeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Esomeprazole Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Esomeprazole Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Esomeprazole Value Chain Analysis
  2. 12.1.1 Esomeprazole Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Esomeprazole Production Mode & Process
  7. 12.2 Esomeprazole Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Esomeprazole Distributors
  10. 12.2.3 Esomeprazole Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst